Bristol-Myers Squibb Co (LTS:0R1F) Other Long Term Assets : $5,045 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Bristol-Myers Squibb Co Other Long Term Assets?

Bristol-Myers Squibb Co's other long-term assets for the quarter that ended in Mar. 2024 was $5,045 Mil.

Bristol-Myers Squibb Co's quarterly other long-term assets increased from Sep. 2023 ($3,377 Mil) to Dec. 2023 ($4,636 Mil) and increased from Dec. 2023 ($4,636 Mil) to Mar. 2024 ($5,045 Mil).

Bristol-Myers Squibb Co's annual other long-term assets declined from Dec. 2021 ($3,094 Mil) to Dec. 2022 ($2,381 Mil) but then increased from Dec. 2022 ($2,381 Mil) to Dec. 2023 ($4,636 Mil).

Bristol-Myers Squibb Co Other Long Term Assets Historical Data

The historical data trend for Bristol-Myers Squibb Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Other Long Term Assets Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

3,005.00

3,039.00

3,094.00

2,381.00

4,636.00

Bristol-Myers Squibb Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															2,369.00	2,859.00	3,377.00	4,636.00	5,045.00

Bristol-Myers Squibb Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Bristol-Myers Squibb Co (LTS:0R1F) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (LTS:0R1F) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (LTS:0R1F) Headlines

No Headlines